In mice model of DN or in vitro model of DN, these Schisandrin A could reduce inflammation factors release (IL-6, INF-γ, and TNF-α), also inhibited MDA activity level, and increased the level of SOD, CAT, and GHS levels (Figure 3). This evidence concerns the gene SOD1 and liver dysplastic nodule.